Keen to break into the top five ranking in the Indian market, Dr. Reddy's Laboratories Ltd. has struck an exclusive sales and distribution agreement with Novartis’ Indian subsidiary for a range of established medicines, strengthening its pain management and women’s health portfolio.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Generics Bulletin for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?